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Summary
The availability of robust quantitative biological mark-
ers that are correlated with qualitative psychiatric phe-
notypes can potentially improve the power of linkage
methods to detect quantitative-trait loci influencing psy-
chiatric disorders. We apply a variance-component
method for joint multipoint linkage analysis of multi-
variate discrete and continuous traits to the extended
pedigree data from the Collaborative Study on the Ge-
netics of Alcoholism, in a bivariate analysis of qualitative
alcoholism phenotypes and quantitative event-related
potentials. Joint consideration of the DSM-IV diagnosis
of alcoholism and the amplitude of the P300 component
of the Cz event-related potential significantly increases
the evidence for linkage of these traits to a chromosome
4 region near the class I alcohol dehydrogenase locus
ADH3. A likelihood-ratio test for complete pleiotropy
is significant, suggesting that the same quantitative-trait
locus influences both risk of alcoholism and the ampli-
tude of the P300 component.
Introduction
Many psychiatric disorders, such as schizophrenia or
alcoholism, are typically diagnosed, at a nominal level,
as a dichotomous trait—that is, on a binary or presence/
absence basis. With some disorders (e.g., bipolar dis-
order), a more refined diagnosis may be possible on an
approximately ordinal scale of severity, but the number
of classes distinguished is relatively few, and the diag-
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nostic classes themselves may not be mutually exclusive.
In general, psychiatric diagnostic systems are largely
classificatory rather than metrical in nature and are sub-
ject to high imprecision, large interobserver variability,
low repeatability, and questions of validity and relevance
(Blackwood et al. 1991; Moldin 1994). In statistical ge-
netic analysis, the discrete nature of psychiatric pheno-
types can result in increased type I error, decreased
power, and reduced ability to detect, localize, and esti-
mate the effect size of quantitative-trait loci (QTLs) that
influence these traits (Xu and Atchley 1996; Duggirala
et al. 1997; Wijsman and Amos 1997).
Although inherently continuous biological characters
that directly quantify psychiatric disorders are unavail-
able, there are often correlated quantitative characters,
disease precursors, or associated risk factors that can be
measured easily. For example, schizophrenia is corre-
lated with a number of altered psychophysiological par-
adigms, such as eye-tracking dysfunction (Holzman et
al. 1973), reduced visual and auditory P300 amplitudes
(Blackwood et al. 1991), and diminished inhibition of
the P50 auditory-evoked response to the second of
paired stimuli (Freedman et al. 1997). In individuals at
risk for alcoholism, the amplitude of the visual P300
component of event-related potentials (ERPs) is signifi-
cantly decreased (Begleiter et al. 1984; Polich et al. 1994;
Porjesz and Begleiter 1996; Porjesz et al. 1998). These
correlated biological markers, or endophenotypes (Ott
1995), can be used to identify relatives of affected in-
dividuals who, on the basis of conventional diagnostic
criteria, would be considered unaffected but who nev-
ertheless are at risk for the disease. To some extent, the
correlated character may also serve to quantify the de-
gree of the associated risk (Blackwood et al. 1991; Por-
jesz et al. 1998).
The availability of a quantitative biological marker
that is correlated with a qualitative disease trait suggests
the possibility of exploiting the joint information content
of the pair of phenotypes, in the search for mediating
genetic factors (McGuffin 1984; Lander 1988; Moldin
1994; Ott 1995; Blangero et al. 1997; Williams et al.
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1999 [in this issue]; Czerwinski et al., in press). As a
demonstration of the potential utility of considering
correlated biological markers in elucidating the genetics
of a psychiatric disorder, we apply the method described
by Williams et al. (1999 [in this issue]) to data, on al-
coholism and event-related potentials, from the Collab-
orative Study on the Genetics of Alcoholism (COGA).
ERPs are neuroelectrical signals in the brain that are
elicited in response to stimuli such as light and sound.
These signals are complex convolutions of exogenous
potentials, influenced by the characteristics of the stim-
ulus, and endogenous potentials, influenced by cognitive
processes, and can be regarded as direct measures of
cognitive activity when the brain is engaged in percep-
tion, memory, and attention. Other properties of ERPs
appear to reflect changes due to aging and brain mat-
uration. Although ERPs are highly variable between in-
dividuals, they are relatively stable within individuals
(Porjesz and Begleiter 1985, 1996; Regan 1989). Unlike
electroencephalograms (EEGs), which monitor collective
neuroelectrical activity, ERPs are highly sensitive to spe-
cific brain functions and provide useful indices to the
cognitive process (Porjesz and Begleiter 1996).
The P3(00) ERP component has been studied exten-
sively in relation to alcoholism (Polich et al. 1994; Por-
jesz and Begleiter 1996; Porjesz et al. 1998). The P300
component is a positive-going signal that occurs ∼300
ms after presentation of a stimulus. The amplitude of
the P300 signal is related to cognitive activity, such as
attention and memory, and to the significance of the
stimulus—that is, factors such as task relevance, unpre-
dictability, infrequency, and motivation (Pritchard 1981;
Regan 1989). The COGA experimental protocol for vi-
sual and auditory P300 paradigms has been described
in detail by Alexander et al. (1994) and Cohen et al.
(1994).
Twin and family studies have demonstrated that P300
characteristics are highly heritable ( ) (Polich2h ≈ .49–.60
and Burns 1987; Rogers and Deary 1991; O’Connor et
al. 1994; van Beijsterveldt et al. 1996; Katsanis et al.
1997; Almasy et al. 1999). Studies have also found that
alcoholics and persons at elevated risk for alcoholism
(e.g., sons of alcoholic fathers) exhibit reduced P300
amplitudes (Begleiter et al. 1984; O’Connor et al. 1987;
Polich et al. 1994). The amplitude reduction is also ob-
served among unaffected and alcohol-naive relatives of
alcoholic probands and persists even in long-
term–abstinent alcoholics (Porjesz and Begleiter 1985,
1996). The reduction in the P300 component in alco-
holics and high-risk males is correlated strongly with
number of alcohol-dependent individuals in a family,
rather than with alcohol intake (Pfefferbaum et al.
1991). These findings suggest that P300 abnormalities
are not functional consequences of alcoholism but, in-
stead, that they antecede alcohol use and dependence
and reflect physiological processes that mediate liability
to alcoholism and other complex, multifactorial psy-
chiatric disorders (Begleiter et al. 1984; Polich et al.
1994; Porjesz and Begleiter 1996).
Data
The families used in this study come from COGA, a
large, multicenter, and multidisciplinary research effort
initiated in 1989 to investigate the genetic factors that
influence susceptibility to alcohol dependence and abuse
(Begleiter et al. 1995). One of the many strengths of the
COGA project is the collection of quantitative neuropsy-
chological and neurophysiological data to complement
the qualitative assessments related to alcoholism and as-
sociated behavioral characteristics.
Probands were systematically recruited from inpatient
and outpatient alcohol-treatment facilities. Subjects who
were affected under both DSM-III-R “dependence” and
Feighner “definite” criteria and who had a qualifying
family structure (either a sibship of at least three indi-
viduals, if parents were available for study, or a larger
sibship, if parents were unavailable) were considered to
be probands and their families were considered to be
stage I families. Probands were not accepted into the
study if they were intravenous drug users, were HIV
positive, suffered a terminal illness unrelated to alcohol
dependence, or were otherwise unable to participate.
All probands, their spouses, and first-degree relatives
who met admission criteria were interviewed by means
of the Semi-Structured Assessment for the Genetics of
Alcoholism (SSAGA) (Bucholz et al. 1994), to assess
adult lifetime psychiatric status. The SSAGA enables al-
coholism dependence, abuse, and harmful use to be di-
agnosed by means of Feighner criteria (Feighner et al.
1972), DSM-III, DSM-III-R, and DSM-IV (American
Psychiatric Association 1980, 1987, 1994), and ICD-10
(World Health Organization 1992) criteria. These di-
agnostic systems are broadly similar in their criteria for
identification of substance dependence, but they differ
considerably in their criteria for substance abuse or
harmful use (Schuckit et al. 1994). The ICD-10 system
focuses on psychological and physical harm occurring
in the context of substance use, and it deliberately ex-
cludes social, interpersonal, and legal problems, whereas
the DSM-III-R and DSM-IV systems are broader and
include psychosocial items. The DSM-III-R and DSM-
IV systems differ with regard to whether certain symp-
toms are indicative of dependence or abuse/harmful use
(Schuckit et al. 1994).
The COGA criterion for alcoholism requires an in-
dividual to meet both the DSM-III-R criteria for alcohol
dependence and the Feighner criteria for alcoholism at
the “definite” level. Subjects who consumed alcohol but
who had no symptoms of alcohol dependence, alcohol
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abuse, or harmful use by any diagnostic system were
considered to be “unaffected.” Subjects who had never
been exposed to alcohol were labeled “unknown,” as
were subjects who had one or more symptoms of alcohol
dependence or abuse but who nevertheless did not meet
the full COGA criterion for alcohol dependence.
If the proband and at least two first-degree relatives
were affected under the COGA diagnosis (parents were
included in the pool of first-degree relatives) and if at
least one parent was unaffected (to avoid bilineal mat-
ings), then the family was considered to be a stage II
family. The pedigree was extended, and family members
were interviewed by means of the SSAGA. Blood samples
were drawn for biochemical analyses and extraction of
DNA, and a battery of neurophysiological and neuro-
psychological tests were administered. Stage II families
were redesignated as stage III when they became avail-
able for genotyping and after the pedigree had been re-
viewed for completeness. Stage IV families are those that
were actually selected for genotyping.
For this study, 105 multigenerational stage IV pedi-
grees comprising 1,219 individuals were available for
genetic linkage analysis. The limiting factor on the use
of these data is the availability of phenotype informa-
tion; in the data examined here, there are 11 full or
partially phenotyped pedigrees with one generation, 55
pedigrees with two generations, 32 with three genera-
tions, and 7 with four generations. The COGA genetic
map used for these analyses comprises 263 markers, with
an average intermarker distance of 13.2 cM.
Methods
Multipoint genome linkage scans were conducted at
2-cM intervals, by means of the analysis package SOLAR
(sequential oligogenic linkage analysis routines) (Almasy
and Blangero 1998) and the joint qualitative-quantita-
tive linkage method described by Williams et al. (1999
[in this issue]). Regions surrounding a signal peak were
examined further with a limited multipoint scan at 1-
cM resolution. As covariates in all analyses, we used age
at SSAGA and sex of the individual. Age effects for males
and females were modeled separately.
Given the extent to which the COGA data are ascer-
tained, we attempted in our analyses to correct for the
nonrandom sampling. The COGA ascertainment scheme
comprises an initial single ascertainment event to obtain
a stage I family, followed by a multiplex ascertainment
event (the proband and at least two first-degree relatives
must be affected) to obtain stage II families and, ulti-
mately, stage IV families. The complexity of this ascer-
tainment makes an exact correction difficult to specify
(Comuzzie and Williams, in press), but some adjustment
is essential in order to recover unbiased estimates of
genetic effects and to maximize the power to detect
linkage.
An approximate correction for ascertainment bias was
made by conditioning the likelihood for each pedigree
on the joint event represented by the observed trait val-
ues of the focal proband and two randomly selected
affected first-degree relatives (Hopper and Mathews
1982; Boehnke and Greenberg 1984; Boehnke et al.
1986; Beaty and Liang 1987). We have therefore cor-
rected for ascertainment as if the COGA stage IV ped-
igrees had been multiplex ascertained (Thompson 1993)
on a focal proband and two secondary probands. Co-
muzzie and Williams (in press) have shown, for the
COGA data, that this correction may be conservative
and may increase the rate of type II errors.
Univariate genome scans were performed initially with
the COGA, DSM-IV, and ICD-10 diagnoses of alco-
holism, to identify regions for further investigation using
multitrait linkage analysis. For these analyses, data were
available for 661 (COGA), 593 (DSM-IV), and 488
(ICD-10) individuals, in 105 stage IV pedigrees.
The results of univariate genome scans for the visual
P300 component of Cz, O2, and T8 ERPs have been
reported elsewhere (Begleiter et al. 1998). These analyses
involved 604 individuals from 100 stage IV COGA ped-
igrees and were not corrected for ascertainment bias.
Subsequent reanalysis of these data to include the as-
certainment correction described above confirmed the
original findings (results not shown).
Bivariate genome scans were performed for the
COGA, DSM-IV, and ICD-10 diagnoses, with the P300
component of the Cz, O2, and Pz ERPs. For these anal-
yses, data on the P300 components for 607 individuals
in 103 stage IV pedigrees were added to the univariate
data on alcoholism. ERPs at the Cz and O2 electrodes
were chosen for study because comparative univariate
genome scans for these ERPs have been reported (Be-
gleiter et al. 1998). The Pz electrode was included be-
cause P300 responses have their maximum amplitude at
this location and because previous studies of reduced
P300 amplitude in abstinent alcoholics and in high-risk
individuals have focused on this electrode (Porjesz and
Begleiter 1996; Porjesz et al. 1998).
Results
Univariate Genome Scan of Alcoholism Diagnosis
Results for the univariate genome scan are summa-
rized in table 1 and figure 1. Linkage analysis with each
alcoholism diagnosis reveals the presence of a signal in
the ADH region of chromosome 4. The location of the
peak is estimated consistently at 99–100 cM, near the
ADH3 locus at 95.2 cM on the COGA map. The strong-
est evidence for linkage ( ) is obtained withLOD = 2.76
the DSM-IV diagnosis, although the COGA and ICD-
10 diagnoses each give a peak LOD score 11.0. The
relative strength of the linkage signal on chromosome 4
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Table 1
Maximum Multipoint LOD Scores on Chromosome 4, in






COGA 99 1.51 6.95 .0042
DSM-IV 100 2.76 12.71 .0002
ICD-10 99 1.33 6.13 .0066
a Under the null hypothesis, the likelihood-ratio statistic l is
distributed as a mixture.1 12 2x : x1 02 2
is evident irrespective of the diagnostic system—no other
signals in the univariate analysis of these diagnoses had
a LOD score 12.0, and only one additional LOD score
was 11.0.
Table 1 gives the location and value of the maximum
LOD score in each univariate analysis shown in figure
1; also given are the value of the likelihood-ratio statistic
l for the test of linkage, along with its corresponding P
value. Under the null hypothesis of no linkage, the like-
lihood-ratio statistic corresponding to the univariate
LOD score is asymptotically distributed as a mix-1 1:2 2
ture of a distribution and a unit point mass at the2x1
origin, denoted by (Hopper and Mathews 1982; Beaty2x0
et al. 1987; Self and Liang 1987; Liang et al. 1996).
Bivariate Genome Scan of Alcoholism Diagnosis and
ERP
In view of the linkage signal on chromosome 4 in
univariate analyses of the discrete alcoholism diagnoses,
bivariate qualitative-quantitative genome scans were un-
dertaken for the COGA, DSM-IV, and ICD-10 diag-
noses, with the P300 component of the Cz, O2, and
Pz ERPs. Results for these analyses are summarized in
table 2.
The bivariate LOD scores in table 2 each have 2 df
and are not directly comparable to the univariate LOD
scores presented in table 1. Under the null hypothesis of
no linkage of either alcoholism or ERP phenotypes to a
QTL, the likelihood-ratio statistic corresponding to the
bivariate LOD score is asymptotically distributed as a
mixture of , , and distributions (Self and1 1 1 2 2 2: : x x x2 1 04 2 4
Liang 1987). Consequently, in table 2, two LOD scores
are given for each bivariate analysis: the true bivariate
LOD score having 2 df and the bivariate LOD score
after adjustment to 1 df, denoted as “LOD[1].” The ad-
justed LOD score is determined as the 1-df LOD score
required to give the same P value as is given by the true
bivariate LOD score and can be compared directly with
the univariate LOD scores in table 1.
Similarly, the support interval for a univar-Z  1max
iate LOD score (Ott 1991) has its bivariate equivalent.
One LOD-score unit under the univariate null distri-
bution corresponds to a P value of .0319.1 12 2( x : x )1 02 2
To obtain the same P value under the bivariate null dis-
tribution requires a LOD score of 1.39;1 1 12 2 2( x : x : x )2 1 04 2 4
thus, the equivalent bivariate support interval is
. (Under the naive assumption that the like-Z  1.39max
lihood-ratio statistics corresponding to the univariate
and bivariate LOD scores follow and distributions,2 2x x1 2
respectively, the corresponding bivariate support interval
would be .)Z  1.50max
With Cz and Pz, the linkage signal on chromosome 4
increases under all diagnostic definitions and remains
strongest with DSM-IV. The greatest evidence for linkage
is obtained with the P300 component of the Cz ERP
electrode, independently of the alcoholism-diagnostic
system. The peak signal location is estimated consistently
at 100–101 cM and is effectively at anonymous marker
D4S250 at 100.4 cM on the COGA map (5.2 cM qter
of ADH3).
One additional significant LOD score and one nearly
significant LOD score were also detected in the bivariate
genome scan. These signals are at 212 cM on chro-
mosome 6, with Cz/ICD-10 ( ,LOD = 3.72 LOD =[1]
), and at 214 cM on chromosome 2, with O2/DSM-3.18
IV ( , ), and they correspondLOD = 3.34 LOD = 2.98[1]
closely with the results reported by Begleiter et al.
(1998). No significant LOD scores were observed in bi-
variate analyses with Pz.
The multipoint LOD scores on chromosome 4 for the
univariate analyses of DSM-IV and Cz, as well as for
the bivariate analysis of Cz/DSM-IV, are plotted on a
common set of axes in figure 2. Also shown is the bi-
variate LOD score after adjustment to 1 df. The curves
for DSM-IV and for Cz/DSM-IV each peak near marker
D4S250 at 100.4 cM. The support interval (OttZ  1max
1991) for the univariate DSM-IV LOD-score curve is
44.6 cM at 1.76. Signal definition is improved in the
bivariate analysis, however, and the corresponding
support interval decreases to 36.6 cM atZ  1.39max
3.36.
Although the LOD-score curves for the univariate and
bivariate analyses in figure 2 have similar profiles, the
LOD-score curve for the bivariate analysis is not simply
the summed contribution of the curves for the individual
univariate analyses of DSM-IV and Cz. The increased
linkage evidence obtained with the joint analysis derives
in part from the underlying correlational structure of the
discrete and continuous traits, even if one of the traits
exhibits little or no evidence for linkage at the same
location when it is studied by means of univariate
methods.
Pleiotropy or Close Linkage?
When multiple traits are analyzed, the mechanisms of
pleiotropy and of close linkage of independent major
genes are of particular biological interest (Jiang and
Zeng 1995; Almasy et al. 1997; Mangin et al. 1998)
and can be tested easily by means of likelihood-ratio
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Table 2
Maximum Multipoint LOD Scores on Chromosome 4, in Bivariate
Linkage Analyses of Three Alcoholism Diagnoses and the P300





Score LOD[1] l P
a
COGA Cz 101 3.17 2.65 14.58 42.38# 10
DSM-IV Cz 101 4.75 4.16 21.89 65.86# 10
ICD-10 Cz 100 2.47 2.00 11.38 31.22# 10
COGA O2 100 1.69 1.27 7.76 37.83# 10
DSM-IV O2 101 3.16 2.64 14.53 42.43# 10
ICD-10 O2 100 1.58 1.18 7.30 39.95# 10
COGA Pz 100 2.35 1.88 10.83 31.61# 10
DSM-IV Pz 101 4.01 3.46 18.45 53.34# 10
ICD-10 Pz 100 1.98 1.54 9.13 33.85# 10
a Under the null hypothesis, the likelihood-ratio statistic l is dis-
tributed as a mixture.1 1 12 2 2x : x : x2 1 04 2 4
Figure 1 Multipoint LOD scores on chromosome 4, in univariate linkage analysis of COGA, DSM-IV, and ICD-10 diagnoses of alcoholism
criteria for nested hypotheses (Williams et al. 1999 [in
this issue]). In the bivariate analysis, the mechanisms of
complete pleiotropy and coincident linkage are special
cases of a general two-QTL genetic linkage model. To
test for complete pleiotropy, in which the same gene
influences variation in both alcoholism and ERP, the
likelihood of a two-QTL linkage model in which the
correlation between the QTLs is estimated is compared
with the likelihood of a restricted model in which the
correlation is constrained to unity. To test for coincident
linkage of the traits to two independent but closely
spaced genes that happen to be linked, the likelihood of
the general linkage model is compared with that of a
restricted model in which the correlation is constrained
to be zero.
Likelihood-ratio tests for pleiotropy and coincident
linkage, made at the location of the peak LOD score
(101 cM) on chromosome 4, for Cz/DSM-IV, are sum-
marized in table 3. For each test, the table gives the
likelihood-ratio statistic l, the asymptotic null distri-
bution, and the corresponding P value. The test against
complete pleiotropy is not significant, but the test against
coincident linkage is moderately so ( ), suggestingP ! .01
that variation in alcoholism and variation in the P300
component of the Cz ERP are indeed mediated by com-
mon genetic factors.
Discussion
The demonstration of ethnic variability in physiolog-
ical responses to alcohol ingestion was one of the earliest
indications that some observed populational differences
were not solely culturally determined (Fenna et al. 1971;
Wolff 1972, 1973; Ewing et al. 1974; Goedde et al.
1979; Shriver 1997). Numerous studies have since es-
tablished that certain liver enzymes modulate the rates
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Table 3
Likelihood-Ratio Tests for Pleiotropy and Coincident Linkage at
101 cM on Chromosome 4, in Bivariate Linkage Analysis of
DSM- IV Alcoholism Phenotype and P300 Component of Cz
ERP
Mechanism Distribution l P
Complete pleiotropy 1 12 2x : x1 02 2 .00 .5000
Coincident linkage 2x1 7.44 .0064
Figure 2 Comparison of multipoint LOD scores on chromosome 4, in univariate and bivariate linkage analyses of DSM-IV alcoholism
diagnosis and P300 component of Cz ERP.
of oxidation of ethanol and its by-products. Allelic var-
iation at the genetic loci coding for these enzymes is
believed to underlie much of the observed two- to three-
fold interindividual variability in the rate of ethanol ox-
idation—and, thereby, to influence drinking behavior
and the risk of development of alcoholism (Stamatoy-
annopoulos et al. 1975; Goedde et al. 1979; Teng et al.
1979; Bosron and Li 1986; Shibuya and Yoshida 1988b;
Shibuya et al. 1989; Thomasson et al. 1991, 1995; Mur-
amatsu et al. 1995; Higuchi et al. 1996; Edenberg and
Bosron 1997; Wall et al. 1997; Osier et al. 1999). To
better understand the relevance of the evidence for link-
age to the ADH region, however, some background in-
formation on alcohol metabolism is useful.
Approximately 90% of ethanol oxidation occurs in
the liver, in a two-stage metabolic process. Ethanol is
initially oxidized to acetaldehyde by alcohol dehydro-
genase (ADH), and acetaldehyde is subsequently oxi-
dized to acetate by aldehyde dehydrogenase (ALDH).
Multiple isozymes of both ADH and ALDH have been
characterized, but the forms primarily involved in eth-
anol elimination are ALDH2 and ADH2 (Bosron and
Li 1986; Smith 1986; Yoshida et al. 1991; Thomasson
et al. 1995; Edenberg and Bosron 1997). The gene en-
coding ALDH2 is located on chromosome 12q24 (Hsu
et al. 1986), and a structural mutation in the gene (a
single-base-pair difference) encodes a mitochondrial iso-
zyme of low catalytic activity (Impraim et al. 1982;
Yoshida et al. 1983, 1984; Hsu et al. 1988). The low-
activity allele ALDH2*2 is dominant over the normal
ALDH2*1 allele, and individuals homozygous or het-
erozygous for ALDH2*2 are ALDH2 deficient and ox-
idize acetaldehyde at a reduced rate (Schwitters et al.
1982; Crabb et al. 1989).
In response to even small amounts of alcohol,
ALDH2-deficient individuals typically experience an
acute, unpleasant “flushing response” that can include
facial flushing, sweating, palpitations, hyperventilation,
tachycardia, nausea, dizziness, and faintness. This al-
cohol-induced flushing response is very similar to the
aversive reaction to alcohol in alcoholic patients being
treated with the ALDH inhibitor disulfiram (Wilkin
1981; Zeiner 1981). The atypical ALDH2*2 allele is
extremely rare in European populations, but it can reach
1154 Am. J. Hum. Genet. 65:1148–1160, 1999
a frequency of 15%–20% in Asian populations, and
the prevalence of ALDH2 deficiency reaches 30%–50%
in Japanese, Korean, and Chinese populations (Goedde
et al. 1979, 1986, 1992; Teng 1981; Shibuya and Yosh-
ida 1988a, 1988b; Thomasson et al. 1991; Shen et al.
1997). The flushing response is correspondingly com-
mon (frequency 50%–80%) in Asian populations but is
much less frequent (5%–10%) in European populations
(Wolff 1972, 1973).
Until recently, the low-activity form of mitochondrial
aldehyde dehydrogenase (i.e., ALDH2) was the only
clearly defined genetic factor known to affect drinking
behavior and the risk of alcoholism, presumably by re-
ducing the rate of hepatic acetaldehyde oxidation. How-
ever, several studies have since established that allelic
variation at the alcohol dehydrogenase loci ADH2 and
ADH3 also influences drinking behavior and risk of al-
coholism, by modulating the rate of acetaldehyde pro-
duction subsequent to intake of ethanol (Thomasson et
al. 1991, 1995; Muramatsu et al. 1995; Chen et al. 1996;
Higuchi et al. 1996; Shen et al. 1997).
The genes encoding the three class I ADH subunits
ADH1, ADH2, and ADH3 are closely linked on chro-
mosome 4q21–23 (Tsukahara and Yoshida 1989; Ya-
sunami et al. 1990; Osier et al. 1999). Polymorphic al-
leles at the ADH2 and ADH3 loci encode isozyme
variants having markedly different kinetic properties
(Bosron and Li 1986; Yoshida et al. 1991; Thomasson
et al. 1995; Edenberg and Bosron 1997). In particular,
the b2b2 homodimeric isozyme encoded by ADH2*2 has
a nearly 40-fold-higher activity (Vmax) than is seen in the
b1b1 homodimer encoded by ADH2*1. In contrast, the
isozyme encoded by ADH3*1 exhibits only 2.5 times
the activity of the ADH3*2 isozyme (Bosron and Li
1986; Edenberg and Bosron 1997). Population studies
of ADH have found that the ADH2*2 allele is rare (fre-
quency !5%) in most European populations but that it
can reach frequencies of 30%–70% in some Asian pop-
ulations (Thomasson et al. 1991; Shen et al. 1997).
A statistical association of the ADH2*1 and
ALDH2*1 alleles with alcoholism has been clearly dem-
onstrated in several Asian populations (Harada et al.
1982, 1985; Shibuya and Yoshida 1988b; Thomasson
et al. 1991; Takeshita et al. 1994; Muramatsu et al.
1995; Higuchi et al. 1996; Shen et al. 1997). In popu-
lations of Taiwanese and Japanese individuals, alcohol-
ics were found to have significantly lower frequencies of
the ADH2*2 and ADH3*1 alleles than were seen in
nonalcoholics, and the difference was independent of the
ALDH2 genotype (Thomasson et al. 1991). The fre-
quency of theALDH2*2 allele, as well as the frequencies
of individuals homozygous and heterozygous for the al-
lele, were also found to be significantly lower in alco-
holics than in nonalcoholics (Harada et al. 1982, 1985;
Shibuya and Yoshida 1988b; Thomasson et al. 1991;
Muramatsu et al. 1995; Higuchi et al. 1996; Shen et al.
1997). Similar results have also been reported in a com-
parison of Japanese flushers and nonflushers (Shibuya
et al. 1989).
Recent studies in different populations have found ev-
idence for linkage of alcoholism diagnoses to the ADH
region of chromosome 4 and, further, suggest that the
linkage is contributed largely by unaffected individuals.
Two-point and multipoint linkage analyses of alcohol-
ism in sibships from the COGA study (Reich et al. 1996,
1998) found that allele sharing in the ADH region is
increased among concordant unaffected pairs and is de-
creased among pairs discordant for diagnosis. In a study
of 172 sib pairs from an American Indian population
containing 18 concordant unaffected sib pairs, Long et
al. (1998), in two-point linkage analysis, found only
nominal evidence for linkage to the ADH region
( ) and, in multipoint analysis, found no ev-.01 ! P ! .05
idence for linkage to the ADH region. The study by
Vallejo et al. (1998) of 135 nuclear families from Finnish
pedigrees, using both Haseman-Elston and multipoint
methods, also failed to find any evidence of linkage to
the ADH region. Vallejo et al. (1998) did not report the
number of concordant unaffected sib pairs in their study,
but the nature of the probands (criminal offenders) sug-
gests that concordant unaffected individuals might have
been uncommon in their sample.
Because the class I ADH genes on chromosome 4 are
such plausible candidates for genetic factors influencing
susceptibility to alcoholism, it is interesting that the peak
linkage signal at 100–101 cM in figures 1 and 2 is offset
slightly from the ADH3 locus at 95.2 cM. This dis-
placement may be a consequence of several more highly
informative markers clustered with ADH3 in a 5.2-cM
region on the COGA map. Located just q-terminal of
ADH3 at 95.2 cM are D4S1628 (98.1 cM), D4S2457
(99.0 cM), and D4S250 (100.4 cM). The diallelicADH3
locus is not very informative (heterozygosity .3496), but
the neighboring markers are considerably more so, with,
respectively, 6, 8, and 16 alleles and heterozygosities
.5670, .7498, and .8131. The COGA marker map is
also relatively dense in the region of ADH3, increasing
the chances of map inaccuracies that could influence the
linkage results.
The LOD-score curves for univariate DSM-IV (fig. 1)
and bivariate Cz/DSM-IV (fig. 2) each exhibit two ad-
ditional relative maxima. The larger of these forms a
slight peak, in the bivariate analysis and in both uni-
variate analyses, near marker D4S2393. The smaller,
secondary peak is less well defined but is located near
the GABRB1 receptor gene, which is also the location
of the strongest linkage finding reported by Long et al.
(1998) for chromosome 4. GABA (gamma-aminobutyric
acid) is the major inhibitory neurotransmitter in the ver-
tebrate CNS, and GABA receptors are known to be
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modulated by a number of pharmacological agents, in-
cluding alcohol (Dean et al. 1991).
There is less evidence of linkage of alcoholism diag-
noses or ERP traits to chromosomal regions containing
loci encoding aldehyde dehydrogenase isozymes. The
genes for ALDH1 and ALDH2 are located on human
chromosomes 9 and 12, respectively (Hsu et al. 1986;
Smith 1986; Yoshida et al. 1991). Univariate linkage
analyses of chromosomes 9 and 12 for the COGA, DSM-
IV, and ICD-10 diagnoses yielded no LOD scores 10.16.
When these diagnoses were reexamined in bivariate
analyses (unconditioned on the chromosome 4 signal)
with P300 amplitude recorded at Cz, we found nonsig-
nificant LOD scores reaching 1.16–1.78 at 8 cM on
chromosome 9 (between D9S917 and GATA62F03)
and 1.11–1.27 at 170 cM on chromosome 12 (near
D12S1045). The genes ALDH1 and ALDH2 are not on
the COGA marker map used for our analyses, but, using
the LDB database (Collins et al. 1996), we determined
that each of them is 150 cM from the LOD-score peaks
on chromosomes 9 and 12, respectively, and therefore
are unlikely to be linked to a QTL for either alcoholism
or ERP. The COGA genetic maps for both chromosomes
are sparse, however, and analysis with additional typed
markers will be required before firm conclusions can be
drawn as to the existence of other linked regions for
alcoholism and ERPs. It will also be of interest to ex-
amine the evidence for linkage at these locations after
conditioning on the signal on chromosome 4 in an ol-
igogenic analysis (Blangero and Almasy 1997; Comuzzie
et al. 1997).
In their sample from an American Indian population,
Long et al. (1998), using a two-point analysis of 172
sib pairs and the DSM-III-R phenotype, reported strong
evidence ( ) for linkage to D11S1984 locatedP = .00007
at chromosome 11p15.5. Our analyses of chromosome
11 yielded nonsignificant LOD scores of 0.79 (COGA),
1.06 (DSM-IV), and 0.71 (ICD-10) in the region be-
tween D11S1999 (41.1 cM) and D11S902 (55.1 cM),
∼22.6–36.6 cM q-terminal of D11S1984 (18.5 cM). The
gene for tryptophan hydroxylase, the rate-limiting en-
zyme in the biosynthesis of the neurotransmitter sero-
tonin and a potential marker for serotonergic behaviors,
is located in this region (Nielsen et al. 1992). The sim-
ilarity of our results to the two-point results of Long et
al. (1998) is suggestive and merits further investigation.
At least two factors could account for the slight differ-
ence, in location of the maximum LOD score, between
the two studies. First, the COGA genetic map for chro-
mosome 11 used for these analyses is inflated (total
length 255.3 cM), which could introduce location bias.
Also, the p-terminal location of D11S1984 on chro-
mosome 11 in the genetic map of Long et al. (1998), as
well as the corresponding lack of flanking markers on
one side, may have biased their estimate of maximum-
LOD-score location.
Our analyses of the COGA stage IV extended pedi-
grees, with and without correction for ascertainment,
did not detect the recently reported nominally significant
( ) linkage of the COGA phenotype to regions ofP ! .01
chromosomes 1, 2, and 7 in multipoint sib-pair analyses
of 987 individuals in 177 nuclear families derived from
the COGA stage IV pedigrees (Reich et al. 1997, 1998).
A multipoint linkage result ( ) suggesting linkageP ! .01
to a chromosome 8 region near D8S549 at 31.2 cM has
also been reported (Reich et al. 1998). In uncorrected
analyses, we found a small peak ( ) in thisLOD = 0.95
region, but the signal was markedly reduced (LOD =
) in the ascertainment-corrected analysis, and the0.32
location of the signal under the COGA diagnosis did
not closely correspond with the locations of the peaks
under the DSM-IV and ICD-10 diagnoses.
The dopamine D2 receptor gene on chromosome
11q22–23 has also been implicated in alcoholism (Blum
et al. 1990; Blum and Noble 1996), but we found no
significant evidence of linkage ( ) in theLOD = 0.58–0.64
region of DRD2 at 179.8 cM on chromosome 11 (Ed-
enberg et al. 1998; Phillips et al. 1998). Similarly, despite
our evidence that the GABRB1 cluster on chromosome
4 is linked to the alcoholism phenotype, there were no
indications of linkage to either of the clusters of GABA
receptor genes on chromosomes 5 and 15 (Sinnett et al.
1993; Russek and Farb 1994). No markers in the
GABRR1–2 region of chromosome 6 (Cutting et al.
1992) were available for linkage analysis, but this region
should be scrutinized further, in view of the evidence for
linkage of some ERP signals to this chromosome (Be-
gleiter et al. 1998).
The failure to detect some of these previously reported
linkage results is not without precedent (Long et al.
1998; Vallejo et al. 1998) and, in our case, may be re-
lated to a number of important differences between the
two studies, in linkage methodology and in data struc-
ture (Wijsman and Amos 1997; Williams and Blangero
1999). For example, the present study uses complete
extended-pedigree information, whereas Reich et al.
(1998) analyzed only the nuclear families derived from
the COGA extended pedigrees and Long et al. (1998)
examined only sib pairs derived from extended pedigrees
in an American Indian population. For highly prevalent
disorders such as alcoholism, the unaffected individuals
can contribute substantially to the overall pedigree like-
lihood, yet, whereas the threshold model for discrete
traits that is described by Duggirala et al. (1997) and
Williams et al. (1999 [in this issue]) makes full use of
affected and unaffected individuals, affected-sib-pair
methods use only affected individuals in making a test
for linkage.
The particular choice of a weighting scheme to at-
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tempt to correct for the nonindependence of sib pairs in
a sib pair–based analysis can also markedly influence
linkage results (Van Eerdewegh et al. 1998). In our var-
iance-component approach, however, the nonindepend-
ence of relative pairs in a pedigree is completely ac-
counted for by maximizing the joint likelihood of each
pedigree, conditional on all its members (Amos et al.
1996; Williams and Blangero 1999), and ad hoc model-
dependent weights are unnecessary. We have, however,
applied an approximate correction for the complex
COGA ascertainment scheme, which may possibly have
increased the rate of type II errors (Comuzzie and Wil-
liams, in press).
Most significantly, the methods used here and in the
studies by Long et al. (1996, 1998) and Reich et al.
(1996, 1998) differ radically in their approach to linkage
analysis (Williams and Blangero 1999). The power of
the sib pair–based method is a function of the sib-pair
relative risk (Risch 1990), whereas the power of the var-
iance-component method is a function of the QTL her-
itability (Almasy and Blangero 1998). Consequently, the
power of each linkage method to detect genes is optimal
for different QTL effect sizes and trait prevalences.
The statistical problems associated with multiple test-
ing are not an issue in the present study. First, we have
intended primarily to present a specific application il-
lustrating the utility of the method described by Williams
et al. (1999 [in this issue]). Thus, whereas none of the
alcoholism diagnoses individually give significant evi-
dence for linkage (table 1), the joint linkage analysis of
DSM-IV and the biologically related endophenotype Cz
does reach significance. Second, this is at least the third
report of linkage of an alcoholism phenotype to the
ADH region; if our results are regarded as a replication
of previously reported linkages, then multiple testing is
again not an issue, and nominal significance values ap-
ply. Finally, we argue that any correction for examina-
tion of multiple, highly correlated phenotypes will be
extremely difficult to determine, because of their non-
independence—clearly, a correction based simply on the
raw number of phenotypes would be overly conser-
vative.
Finally, although strong evidence for linkage of the
alcoholism phenotype to the ADH region of chromo-
some 4 is detected by each diagnostic system, it is in-
teresting to note that neither the most narrowly biolog-
ical definition of alcoholism (i.e., that of ICD-10) nor
the rigorous and broadly psychosocial COGA diagnosis
(which requires both the DSM-III-R criteria for alcohol
dependence and the Feighner criteria for alcoholism at
the “definite” level) generates the greatest evidence for
linkage. Considering the difficulties inherent in the def-
inition of phenotypes relating to alcohol-use disorders
(Hill 1998), confirmed linkage on the basis of existing
diagnostic measures, such as DSM-IV, to a particular
chromosomal region could prove valuable in the eval-
uation and refinement of future diagnostic criteria for
use in the study of alcoholism and related disorders.
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